Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling
NCT ID: NCT05132868
Last Updated: 2024-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2021-05-25
2023-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Videos to Improve Patient Knowledge on Prenatal Genetics
NCT03816423
Improving Informed Decision Making for Cancer Clinical Trial Participation
NCT03820687
Trial of Strategies to Communicate Genetic Information to Different Ethnic Subpopulations
NCT03023735
Testing Decision Aids About Early Stage Prostate Cancer
NCT02053389
Testing the Helpfulness of 2 Decision Aids for Prostate Cancer
NCT00432601
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pre-educated with educational video
Participants will receive a message to view educational videos prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The video will be shared with patients via MyHealth in the "education" tab in advance of the genetic counseling session
Educational video and pamphlet
The primary intervention in this study is watching the video or reading the pamphlet in advance of the genetic counseling session, which overview the same information that we currently provide in-person/via telehealth during the genetic counseling session.
Traditional genetic counseling
Patients will receive traditional genetic counseling
pre-educated with pamphlet
Participants will receive a message to view a pamphlet prior to their genetic counseling appointment if they are assigned to a pre-educated arm. The pamphlet will be sent to patients who cannot access the video via regular mail in advance of the genetic counseling session
Educational video and pamphlet
The primary intervention in this study is watching the video or reading the pamphlet in advance of the genetic counseling session, which overview the same information that we currently provide in-person/via telehealth during the genetic counseling session.
Traditional genetic counseling
Patients will receive traditional genetic counseling
educated during the session
Participants will receive traditional genetic counseling. . After the genetic counseling session, they will fill out a validated survey called the Multi-dimensional Measure of Informed Choice (MMIC) that assesses attitudes, knowledge, and uptake of genetic testing
Traditional genetic counseling
Patients will receive traditional genetic counseling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational video and pamphlet
The primary intervention in this study is watching the video or reading the pamphlet in advance of the genetic counseling session, which overview the same information that we currently provide in-person/via telehealth during the genetic counseling session.
Traditional genetic counseling
Patients will receive traditional genetic counseling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has a personal or family history of cancer
* If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
* Personal or family history of breast cancer
* English is preferred language
* If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
* Personal or family history of prostate cancer
* English is preferred language
* If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
* Personal or family history of any type of cancer
* Referred based on a variant identified during tumor genomic analysis
* English is preferred language
* If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
* Personal or family history of gastrointestinal or gynecologic cancer
* Screened positive for Lynch Syndrome based on IHC or MMR testing
* English is preferred language
* If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
* Personal or family history of ovarian, and/or pancreatic cancer
* English is preferred language
* If assigned to the arm where they need to be pre-educated with a video or pamphlet, attests that they viewed the video or pamphlet
Exclusion Criteria
* Individuals who are decisionally impaired
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Ford
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Ford, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VAR0214
Identifier Type: OTHER
Identifier Source: secondary_id
NCI-2022-00606
Identifier Type: OTHER
Identifier Source: secondary_id
IRB-61374
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.